tetano
Editor, Senior Moderator
J Am Coll Cardiol. 2020 Mar 18. pii: S0735-1097(20)34637-4. doi: 10.1016/j.jacc.2020.03.031. [Epub ahead of print]
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic.
Driggin E[SUP]1[/SUP], Madhavan MV[SUP]2[/SUP], Bikdeli B[SUP]3[/SUP], Chuich T[SUP]1[/SUP], Laracy J[SUP]1[/SUP], Bondi-Zoccai G[SUP]4[/SUP], Brown TS[SUP]5[/SUP], Nigoghossian C[SUP]1[/SUP], Zidar DA[SUP]6[/SUP], Haythe J[SUP]1[/SUP], Brodie D[SUP]1[/SUP], Beckman JA[SUP]7[/SUP], Kirtane AJ[SUP]2[/SUP], Stone GW[SUP]8[/SUP], Krumholz HM[SUP]9[/SUP], Parikh SA[SUP]10[/SUP].
Author information
Abstract
The coronavirus disease-2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 that has significant implications for the cardiovascular care of patients. First, those with COVID-19 and preexisting cardiovascular disease (CVD) have an increased risk of severe disease and death. Second, infection has been associated with multiple direct and indirect cardiovascular complications including acute myocardial injury, myocarditis, arrhythmias and venous thromboembolism. Third, therapies under investigation for COVID-19 may have cardiovascular side effects. Fourth, the response to COVID-19 can compromise the rapid triage of non-COVID-19 patients with cardiovascular conditions. Finally, the provision of cardiovascular care may place health care workers in a position of vulnerability as they become host or vectors of virus transmission. We hereby review the peer-reviewed and preprint literature pertaining to cardiovascular considerations related to COVID-19 and highlight gaps in knowledge that require further study pertinent to patients, health care workers, and health systems.
Copyright ? 2020. Published by Elsevier Inc.
KEYWORDS:
cardiovascular therapy; coronavirus; health system
PMID:32201335DOI:10.1016/j.jacc.2020.03.031
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic.
Driggin E[SUP]1[/SUP], Madhavan MV[SUP]2[/SUP], Bikdeli B[SUP]3[/SUP], Chuich T[SUP]1[/SUP], Laracy J[SUP]1[/SUP], Bondi-Zoccai G[SUP]4[/SUP], Brown TS[SUP]5[/SUP], Nigoghossian C[SUP]1[/SUP], Zidar DA[SUP]6[/SUP], Haythe J[SUP]1[/SUP], Brodie D[SUP]1[/SUP], Beckman JA[SUP]7[/SUP], Kirtane AJ[SUP]2[/SUP], Stone GW[SUP]8[/SUP], Krumholz HM[SUP]9[/SUP], Parikh SA[SUP]10[/SUP].
Author information
Abstract
The coronavirus disease-2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 that has significant implications for the cardiovascular care of patients. First, those with COVID-19 and preexisting cardiovascular disease (CVD) have an increased risk of severe disease and death. Second, infection has been associated with multiple direct and indirect cardiovascular complications including acute myocardial injury, myocarditis, arrhythmias and venous thromboembolism. Third, therapies under investigation for COVID-19 may have cardiovascular side effects. Fourth, the response to COVID-19 can compromise the rapid triage of non-COVID-19 patients with cardiovascular conditions. Finally, the provision of cardiovascular care may place health care workers in a position of vulnerability as they become host or vectors of virus transmission. We hereby review the peer-reviewed and preprint literature pertaining to cardiovascular considerations related to COVID-19 and highlight gaps in knowledge that require further study pertinent to patients, health care workers, and health systems.
Copyright ? 2020. Published by Elsevier Inc.
KEYWORDS:
cardiovascular therapy; coronavirus; health system
PMID:32201335DOI:10.1016/j.jacc.2020.03.031